Shoulder Innovations (NYSE:SI) Major Shareholder Healthcare Holding B.V. Gilde Sells 10,751 Shares

Shoulder Innovations, Inc. (NYSE:SI) major shareholder Healthcare Holding B.V. Gilde sold 10,751 shares of the company’s stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $22.71, for a total transaction of $244,155.21. Following the transaction, the insider directly owned 2,321,452 shares of the company’s stock, valued at approximately $52,720,174.92. This represents a 0.46% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Large shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Healthcare Holding B.V. Gilde also recently made the following trade(s):

• On Tuesday, August 4th, Healthcare Holding B.V. Gilde sold 99,812 shares of Shoulder Innovations stock. The stock was sold at an average price of $22.77, for a total transaction of $2,272,719.24.
• On Friday, July 31st, Healthcare Holding B.V. Gilde sold 20,034 shares of Shoulder Innovations stock. The shares were sold at an average price of $22.73, for a total transaction of $455,372.82.
• On Thursday, July 30th, Healthcare Holding B.V. Gilde sold 28,245 shares of Shoulder Innovations stock. The stock was sold at an average price of $23.36, for a total transaction of $659,803.20.

Shoulder Innovations Trading Down 0.6%

Shares of NYSE SI traded down $0.13 during trading on Wednesday, hitting $22.56. 54,832 shares of the company traded hands, compared to its average volume of 92,520. The firm has a market capitalization of $467.89 million and a P/E ratio of -0.14. The company has a quick ratio of 10.04, a current ratio of 11.81 and a debt-to-equity ratio of 0.11. The company has a 50-day moving average price of $19.50 and a 200-day moving average price of $15.92. Shoulder Innovations, Inc. has a 1 year low of $10.92 and a 1 year high of $24.59.

Shoulder Innovations (NYSE:SI) last posted its earnings results on Wednesday, May 13th. The company reported ($0.41) earnings per share for the quarter, beating the consensus estimate of ($0.44) by $0.03. Shoulder Innovations had a negative net margin of 81.78% and a negative return on equity of 35.11%. The business had revenue of $16.71 million for the quarter. On average, equities analysts predict that Shoulder Innovations, Inc. will post -1.67 EPS for the current year.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. UBS Group initiated coverage on shares of Shoulder Innovations in a research note on Tuesday, July 28th. They set a “buy” rating and a $27.00 price objective on the stock. Weiss Ratings raised shares of Shoulder Innovations from a “sell (d-)” rating to a “sell (d)” rating in a report on Monday. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $19.00 price target (up from $18.00) on shares of Shoulder Innovations in a research note on Friday, May 8th. Six research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $22.00.

Institutional Trading of Shoulder Innovations

Hedge funds have recently made changes to their positions in the stock. Bank of America Corp DE raised its holdings in Shoulder Innovations by 43.7% in the first quarter. Bank of America Corp DE now owns 26,983 shares of the company’s stock valued at $392,000 after acquiring an additional 8,205 shares in the last quarter. Royal Bank of Canada grew its holdings in Shoulder Innovations by 7,046.3% during the 1st quarter. Royal Bank of Canada now owns 53,883 shares of the company’s stock worth $783,000 after acquiring an additional 53,129 shares in the last quarter. KCM Capital Inc bought a new stake in shares of Shoulder Innovations in the 1st quarter worth about $509,000. Roubaix Capital LLC raised its stake in shares of Shoulder Innovations by 61.9% in the 1st quarter. Roubaix Capital LLC now owns 257,121 shares of the company’s stock valued at $3,736,000 after purchasing an additional 98,305 shares in the last quarter. Finally, Bank of New York Mellon Corp bought a new position in shares of Shoulder Innovations during the first quarter worth about $252,000.

Shoulder Innovations Company Profile

Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.

In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.